Filing Details

Accession Number:
0000914208-25-000062
Form Type:
13G Filing
Publication Date:
2025-02-06 19:00:00
Filed By:
Invesco Ltd.
Company:
Adma Biologics Inc. (NASDAQ:ADMA)
Filing Date:
2025-02-07
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Invesco Ltd. 0 11,296,255 4.8%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G


 
Invesco Ltd.
 
Signature:Robert R. Leveille
Name/Title:Global Head of Compliance
Date:02/06/2025